VENTURE CAPITAL

We use an integrative research process that drives success by unifying naturally divergent perspectives, capabilities, skill sets, and relationships. The process integrates 1) dynamic investment research on thousands of publicly traded and privately held companies with 2) thousands of relationships among executives, investors, and other key participants in our focus areas.

Technology / SaaS
Healthcare
Environmental Technology
SELECT PORTFOLIO COMPANIES
First Analysis is a leading venture capital investor. We have one of the longest records in venture capital, having invested more than $800 million across multiple highly diversified funds over four decades. First Analysis invests mainly in North America with a focus on our sectors of expertise: Technology/SaaS, Healthcare, and Environmental Technology.
We help established companies become profitable leaders in large markets, funding growth plans and working closely with management in areas including strategy, recruitment, sales and marketing, and corporate development. Our flexible approach targets investing $3-10 million as lead investor or as a syndicate partner bringing valuable perspective.

Submit a business plan

Click here to e-mail a business plan.

First Analysis generally invests to expand and grow companies with proven business models and demonstrable customer successes. If you believe an investment in your company is suitable given these general criteria, we would like to learn more about your opportunity. With the information you provide, we can quickly route your information to a First Analysis venture professional who specializes in your industry and who will review and respond to your inquiry.

VENTURE CAPITAL NEWS
First Analysis invests in Fortress Information Security, a risk management solution provider
First Analysis, a leading venture capital investor, has made a new investment in Fortress Information Security, an information security and cyber risk mitigation company that has redefined traditional risk management. Fortress combines automation, continuous monitoring, vulnerability scanning and other powerful technology with human assets to deliver risk management solutions for critical infrastructure clients such as electric utilities.
August 04, 2020
First Analysis, a leading venture capital investor, has made a new investment in Fortress Information Security, an information security and cyber risk mitigation company that has redefined traditional risk management. Fortress combines automation, continuous monitoring, vulnerability scanning and other powerful technology with human assets to deliver risk management solutions for critical infrastructure clients such as electric utilities.
August 04, 2020
First Analysis invests in VIDA, the leader in AI-powered lung imaging analysis
First Analysis, a leading venture capital investor, has made a new investment in VIDA Diagnostics Inc. (VIDA). VIDA provides the new standard of pulmonary care by using AI-powered CT imaging software and services to aid early detection, evaluation, and treatment planning for patients with or at risk of lung diseases. First Analysis led an $11 million initial close of the Series C round to accelerate the commercialization of VIDA’s LungPrint® solution suite.
March 17, 2020
First Analysis, a leading venture capital investor, has made a new investment in VIDA Diagnostics Inc. (VIDA). VIDA provides the new standard of pulmonary care by using AI-powered CT imaging software and services to aid early detection, evaluation, and treatment planning for patients with or at risk of lung diseases. First Analysis led an $11 million initial close of the Series C round to accelerate the commercialization of VIDA’s LungPrint® solution suite.
March 17, 2020
First Analysis invests in innovative eClinical solution provider 4G Clinical
First Analysis, a leading venture capital investor, has made a new minority investment in 4G Clinical. 4G Clinical is a global leader in randomization and trial supply management (RTSM) for the life sciences industry. First Analysis participated in the investment along with existing investors.
January 29, 2020
First Analysis, a leading venture capital investor, has made a new minority investment in 4G Clinical. 4G Clinical is a global leader in randomization and trial supply management (RTSM) for the life sciences industry. First Analysis participated in the investment along with existing investors.
January 29, 2020
©2020 by First Analysis Corporation.
One South Wacker Drive
  ·  
Suite 3900
  ·  
Chicago, IL 60606
  ·  
312-258-1400